PANDA Migraine: Pediatric vs Adult Neurochemistry Differences Across Migraine

Summary

This study looks at how migraines affect the brain at different ages. We will compare brain imaging of people with chronic migraine (at least 15 headache attack days/month) to those without and we want to compare children/youth and adults. This will help us find differences and similarities between adults and youth with migraine with the expectation that better understanding migraine will lead to better treatments in future. This study will have four groups: 1) children/youth (age 8-18y) with chronic migraine, 2) children/youth (age 8-18 y) without migraine, 3) adults (age 30-50y) with chronic migraine, and 4) adults (age 30-50y) without migraine.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 7 to 50

Accepts healthy participants: Yes

Inclusion criteria:

1) Children / youth aged 8-18 with and without migraines
2) Adults aged 30-50 with and without migraines
3) Ability to speak, understand, and read English

Exclusion criteria:

You are not eligible to participate if you are:
1) significant medical comorbidity (i.e., epilepsy or arthritis)
2) significant global developmental delay or intellectual disability
3) Participants that have internal metallic devices that are not safe for MRI
4) Participants who may be pregnant

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

email: panda.migraine@ucalgary.ca phone: 403-955-5733

Principal investigator:

Ashley Harris

Clinical trial:

No

REB-ID:

REB25-0660